Renal Cell Carcinoma

Thomas E. Hutson, DO, PharmD, shares insight on the role of combination therapy and recent advances for the management of renal cell carcinoma.

EP. 1: Overview of Renal Cell Carcinoma (RCC)

June 29th 2021

Thomas E. Hutson, DO, PharmD, provides insight on the diagnosis of renal cell carcinoma (RCC) and discusses classic signs and symptoms of the disease.

EP. 2: Classification of Renal Cell Carcinoma

June 29th 2021

An expert in urologic oncology reviews the staging, grade, and types of renal cell carcinoma.

EP. 3: Approaching Treatment for RCC

July 6th 2021

Kidney cancer expert, Dr Thomas E. Hutson, comments on treatment approaches for the management of renal cell carcinoma.

EP. 4: Goals of Therapy for RCC

July 6th 2021

Thomas E. Hutson, DO, PharmD, discusses the historic and current goals of therapy for the treatment of RCC.

EP. 5: Recent Advances in RCC Treatment

July 13th 2021

Dr Thomas E. Hutson shares insight on recent advances for the treatment of RCC including the role of and VEGF inhibitors, immune therapy, and mTOR inhibitors.

EP. 6: Phase 3 CLEAR Trial in mRCC

July 13th 2021

An expert in kidney cancer reviews the phase 3 CLEAR trial for frontline metastatic renal cell carcinoma.

EP. 7: Emerging Agents for the Treatment of RCC

July 20th 2021

Urologic oncology expert, Dr Thomas E. Hutson, reviews additional agents and clinical trials in the pipeline for the treatment of RCC.

EP. 8: Treatment Selection for the Management of RCC

July 20th 2021

Thomas E. Hutson, DO, PharmD, discusses his approach to determining the optimal initial therapy for a patient with RCC.

EP. 9: Managing Adverse Events in RCC

July 27th 2021

Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.

EP. 10: Role of Combination Therapy in RCC Management

July 27th 2021

Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.